Cocrystal Pharma Inc. Stock
Your prediction
Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. took a tumble today and lost -€0.035 (-4.700%).
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | -4.700% | -8.974% | -22.826% | -55.063% | -12.883% | -70.168% | -93.672% |
| Pacira Pharmaceuticals | -2.560% | 0.885% | 4.587% | 21.925% | 5.556% | -29.630% | -53.659% |
| Supernus Pharmaceuticals | -2.030% | -4.455% | -6.763% | 26.974% | -10.233% | 40.876% | 75.455% |
| Collegium Pharmaceutical Inc | -1.920% | -1.290% | -2.548% | 19.531% | -26.087% | 50.000% | 48.544% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat